{"id":2296,"date":"2020-10-23T13:00:00","date_gmt":"2020-10-23T11:00:00","guid":{"rendered":"https:\/\/sedanamedical.com\/mfn_news\/sedana-medicals-valberedning-utsedd-4\/"},"modified":"2025-05-26T10:27:08","modified_gmt":"2025-05-26T08:27:08","slug":"sedana-medicals-valberedning-utsedd-4","status":"publish","type":"mfn_news","link":"https:\/\/sedanamedical.com\/sv\/mfn_news\/sedana-medicals-valberedning-utsedd-4\/","title":{"rendered":"Sedana Medicals valberedning utsedd"},"content":{"rendered":"<div class=\"mfn-preamble\"><strong>Sedana Medical AB (publ) meddelar idag att i enlighet med beslut p&aring; &aring;rsst&auml;mman den 19 maj 2020 har styrelsens ordf&ouml;rande kontaktat bolagets tre r&ouml;stm&auml;ssigt st&ouml;rsta &auml;gare eller &auml;gargrupper som var och en erbj&ouml;ds att utse en representant att, tillsammans med styrelsens ordf&ouml;rande, utg&ouml;ra valberedning.<\/strong><\/div>\n<p class=\"mfn-wp-retain\"><span><span><span><span>Sedana Medicals valberedning inf&ouml;r &aring;rsst&auml;mman 2021 utg&ouml;rs av: <\/span><\/span><\/span><\/span><\/p>\n<ul>\n<li><span><span><span><span>Thomas Eklund, styrelseordf&ouml;rande <\/span><\/span><\/span><\/span><\/li>\n<li><span><span><span><span>Karl Tobieson, utsedd av Linc AB<\/span><\/span><\/span><\/span><\/li>\n<li><span><span><span><span>Malin Bj&ouml;rkmo, utsedd av Handelsbanken Fonder<\/span><\/span><\/span><\/span><\/li>\n<li><span><span><span><span>Caroline Sj&ouml;sten, utsedd av Swedbank Robur Fonder<\/span><\/span><\/span><\/span><\/li>\n<\/ul>\n<p class=\"mfn-wp-retain\"><span><span><span><span>Karl Tobieson &auml;r utsedd till valberedningens ordf&ouml;rande.<\/span><\/span><\/span><\/span><\/p>\n<p class=\"mfn-wp-retain\"><span><span><span><span>Valberedningen representerar tillsammans 26,7 procent av r&ouml;stetalet f&ouml;r samtliga r&ouml;stber&auml;ttigade aktier i bolaget per 30 september 2020. <\/span><\/span><\/span><\/span><\/p>\n<p class=\"mfn-wp-retain\"><span><span><span><span>Valberedningens uppgift &auml;r att inf&ouml;r &aring;rsst&auml;mman 2021 framl&auml;gga f&ouml;rslag till val av styrelseordf&ouml;rande och &ouml;vriga ledam&ouml;ter i styrelsen, styrelsearvoden och annan ers&auml;ttning till styrelseledam&ouml;terna samt val och arvodering av revisorer. <\/span><\/span><\/span><\/span><\/p>\n<p class=\"mfn-wp-retain\"><span><span><span><span><span>Aktie&auml;gare som &ouml;nskar l&auml;mna f&ouml;rslag till Sedana Medicals valberedning kan g&ouml;ra det via e-post till corp@sedanamedical.com senast den 31 januari 2021.<\/span><\/span><\/span><\/span><\/span><br \/>\n&nbsp;<\/p>\n<p class=\"mfn-wp-retain\"><span><span><span><span><span>F&ouml;r ytterligare information, kontakta:<\/span><\/span><\/span><\/span><\/span><\/p>\n<p class=\"mfn-wp-retain\"><span><span><span><span><span>Valberedningens ordf&ouml;rande, Karl Tobieson<br \/>\nTelefon: +46 70&nbsp;935 85 74<\/span><\/span><\/span><\/span><\/span><\/p>\n<p class=\"mfn-wp-retain\"><span><span><span><span><span>e-mail: <\/span><\/span><a href=\"mailto:karl.tobieson@medcap.se\" rel=\"nofollow\"><span>karl.tobieson@medcap.se<\/span><\/a><\/span><\/span><\/span><\/p>\n<p class=\"mfn-wp-retain\"><span><em><span><span>Sedana Medical &auml;r noterat p&aring; Nasdaq First North Growth Market Sweden.<br \/>\nBolagets Certified Adviser &auml;r Erik Penser Bank, +46 8 463 83 00.<\/span><\/span><\/em><\/span><\/p>\n<p class=\"mfn-wp-retain\"><span><span><em><span><span><span>Informationen l&auml;mnades, genom ovanst&aring;ende kontaktpersoners f&ouml;rsorg, f&ouml;r offentligg&ouml;rande den 23 oktober 2020, kl. 13.00 (CET).<\/span><\/span><\/span><\/em><br \/>\n<strong><span><span><span>______________________<\/span><\/span><\/span><\/strong>&nbsp;<\/span><\/span><\/p>\n<p class=\"mfn-wp-retain\"><span><span><strong><span><span><span>Om Sedana Medical&nbsp;<\/span><\/span><\/span><\/strong><\/span><\/span><\/p>\n<p class=\"mfn-wp-retain\"><span><span><span><span><span>Sedana Medical AB (publ) har utvecklat och s&auml;ljer den medicintekniska produktfamiljen AnaConDa f&ouml;r administrering av volatila anestetika. Genom en kombinationsbehandling av AnaConDa och l&auml;kemedelskandidaten IsoConDa (isofluran) tillhandah&aring;ller Sedana Medical inhalationssedering f&ouml;r mekaniskt ventilerade intensivv&aring;rdspatienter. Bolaget arbetar f&ouml;r att f&aring; marknadsgodk&auml;nnande i Europa f&ouml;r inhalationssedering p&aring; intensivv&aring;rden med l&auml;kemedlet IsoConDa&reg; (isofluran) under andra halv&aring;ret 2021.&nbsp;<\/span><\/span><\/span><\/span><\/span><\/p>\n<p class=\"mfn-wp-retain\"><span><span><span><span><span>Det finns flera utmaningar f&ouml;r b&aring;de patienter och sjukv&aring;rd med dagens intraven&ouml;sa standardbehandling som inhalationssedering l&ouml;ser. Idag ber&auml;knas det finnas mellan sju till &aring;tta miljoner patienter som sederas p&aring; grund av mekanisk ventilering i intensivv&aring;rden globalt, j&auml;mnt f&ouml;rdelade mellan regionerna USA, Europa och Asien. Dessa patienter &auml;r sederade i genomsnitt tre till fyra dagar. Sedana Medical uppskattar den totala marknadspotentialen till 20&ndash;30 miljarder kronor. Tre &aring;r efter marknadsgodk&auml;nnande i Europa r&auml;knar Sedana Medical med en f&ouml;rs&auml;ljning om 500 miljoner kronor i Europa och en EBITDA-marginal p&aring; cirka 40 procent. Bolaget har inlett aktiviteter f&ouml;r att n&aring; marknadsgodk&auml;nnande p&aring; andra marknader utanf&ouml;r EU och en process f&ouml;r att f&aring; marknadsgodk&auml;nnande i USA 2024.<\/span><\/span><\/span><\/span><\/span><\/p>\n<p class=\"mfn-wp-retain\"><span><span><span><span><span>Sedana Medical har egen f&ouml;rs&auml;ljning i Benelux, Norden, Tyskland, Frankrike, Storbritannien och Spanien, samt externa distribut&ouml;rer i &ouml;vriga delar av Europa, Australien, Indien, Israel, Japan, Kanada, Kina, Mexico och Sydkorea. Bolaget grundades 2005, har sitt huvudkontor i Stockholm och bedriver medicinteknisk utveckling p&aring; Irland.<\/span><\/span><\/span><\/span><\/span><\/p>\n<div class=\"mfn-footer\"><\/div>\n<div class=\"mfn-footer mfn-about\"><\/div>\n<script>\n                Array.prototype.slice.call(document.querySelectorAll(\".mfn-footer.mfn-attachment\")).forEach(function (el) { el.remove() });\n            <\/script>\n        <div class=\"mfn-attachments-container\"><div class=\"mfn-attachment mfn-primary\"><a class=\"mfn-attachment-link\" href=\"https:\/\/storage.mfn.se\/proxy\/pm-sedana-medical-publ-valberedning-23-okt-2020.pdf?url=https%3A%2F%2Fmb.cision.com%2FMain%2F15764%2F3221956%2F1323398.pdf\"><span class=\"mfn-attachment-icon\"><img decoding=\"async\" src=\"https:\/\/storage.mfn.se\/proxy\/pm-sedana-medical-publ-valberedning-23-okt-2020.pdf?url=https%3A%2F%2Fmb.cision.com%2FMain%2F15764%2F3221956%2F1323398.pdf&type=jpg\"><\/span>PM Sedana Medical (publ) Valberedning 23 Okt 2020<\/a><\/div><\/div>","protected":false},"excerpt":{"rendered":"<p>Sedana Medical AB (publ) meddelar idag att i enlighet med beslut p&aring; &aring;rsst&auml;mman den 19 maj 2020 har styrelsens ordf&ouml;rande kontaktat bolagets tre r&ouml;stm&auml;ssigt st&ouml;rsta &auml;gare eller &auml;gargrupper som var och en erbj&ouml;ds att utse en representant att, tillsammans med styrelsens ordf&ouml;rande, utg&ouml;ra valberedning. Sedana Medicals valberedning inf&ouml;r &aring;rsst&auml;mman 2021 utg&ouml;rs av: Thomas Eklund, styrelseordf&ouml;rande [&hellip;]<\/p>\n","protected":false},"template":"","class_list":["post-2296","mfn_news","type-mfn_news","status-publish","hentry","mfn-news-tag-mfn-ci_sv-sv","mfn-news-tag-mfn-type-ir_sv-sv","mfn-news-tag-mfn-regulatory-listing_sv-sv","mfn-news-tag-mfn_sv-sv","mfn-news-tag-mfn-regulatory_sv-sv","mfn-news-tag-mfn-lang-sv_sv-sv","mfn-news-tag-mfn-ci-nomination_sv-sv"],"acf":[],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.5 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Sedana Medicals valberedning utsedd - Sedana Medical<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/sedanamedical.com\/sv\/mfn_news\/sedana-medicals-valberedning-utsedd-4\/\" \/>\n<meta property=\"og:locale\" content=\"sv_SE\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Sedana Medicals valberedning utsedd - Sedana Medical\" \/>\n<meta property=\"og:description\" content=\"Sedana Medical AB (publ) meddelar idag att i enlighet med beslut p&aring; &aring;rsst&auml;mman den 19 maj 2020 har styrelsens ordf&ouml;rande kontaktat bolagets tre r&ouml;stm&auml;ssigt st&ouml;rsta &auml;gare eller &auml;gargrupper som var och en erbj&ouml;ds att utse en representant att, tillsammans med styrelsens ordf&ouml;rande, utg&ouml;ra valberedning. Sedana Medicals valberedning inf&ouml;r &aring;rsst&auml;mman 2021 utg&ouml;rs av: Thomas Eklund, styrelseordf&ouml;rande [&hellip;]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/sedanamedical.com\/sv\/mfn_news\/sedana-medicals-valberedning-utsedd-4\/\" \/>\n<meta property=\"og:site_name\" content=\"Sedana Medical\" \/>\n<meta property=\"article:modified_time\" content=\"2025-05-26T08:27:08+00:00\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Ber\u00e4knad l\u00e4stid\" \/>\n\t<meta name=\"twitter:data1\" content=\"3 minuter\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/sedanamedical.com\\\/sv\\\/mfn_news\\\/sedana-medicals-valberedning-utsedd-4\\\/\",\"url\":\"https:\\\/\\\/sedanamedical.com\\\/sv\\\/mfn_news\\\/sedana-medicals-valberedning-utsedd-4\\\/\",\"name\":\"Sedana Medicals valberedning utsedd - Sedana Medical\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/sedanamedical.com\\\/#website\"},\"datePublished\":\"2020-10-23T11:00:00+00:00\",\"dateModified\":\"2025-05-26T08:27:08+00:00\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/sedanamedical.com\\\/sv\\\/mfn_news\\\/sedana-medicals-valberedning-utsedd-4\\\/#breadcrumb\"},\"inLanguage\":\"sv-SE\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/sedanamedical.com\\\/sv\\\/mfn_news\\\/sedana-medicals-valberedning-utsedd-4\\\/\"]}]},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/sedanamedical.com\\\/sv\\\/mfn_news\\\/sedana-medicals-valberedning-utsedd-4\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/sedanamedical.com\\\/sv\\\/hem\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"MFN News Items\",\"item\":\"https:\\\/\\\/sedanamedical.com\\\/mfn_news\\\/\"},{\"@type\":\"ListItem\",\"position\":3,\"name\":\"Sedana Medicals valberedning utsedd\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/sedanamedical.com\\\/#website\",\"url\":\"https:\\\/\\\/sedanamedical.com\\\/\",\"name\":\"Sedana Medical\",\"description\":\"Inhaled Sedation\",\"publisher\":{\"@id\":\"https:\\\/\\\/sedanamedical.com\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/sedanamedical.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"sv-SE\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/sedanamedical.com\\\/#organization\",\"name\":\"Sedana Medical\",\"url\":\"https:\\\/\\\/sedanamedical.com\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"sv-SE\",\"@id\":\"https:\\\/\\\/sedanamedical.com\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"https:\\\/\\\/i0.wp.com\\\/sedanamedical.com\\\/wp-content\\\/uploads\\\/2024\\\/05\\\/sm_icon_neg.png?fit=787%2C1182&ssl=1\",\"contentUrl\":\"https:\\\/\\\/i0.wp.com\\\/sedanamedical.com\\\/wp-content\\\/uploads\\\/2024\\\/05\\\/sm_icon_neg.png?fit=787%2C1182&ssl=1\",\"width\":787,\"height\":1182,\"caption\":\"Sedana Medical\"},\"image\":{\"@id\":\"https:\\\/\\\/sedanamedical.com\\\/#\\\/schema\\\/logo\\\/image\\\/\"}}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Sedana Medicals valberedning utsedd - Sedana Medical","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/sedanamedical.com\/sv\/mfn_news\/sedana-medicals-valberedning-utsedd-4\/","og_locale":"sv_SE","og_type":"article","og_title":"Sedana Medicals valberedning utsedd - Sedana Medical","og_description":"Sedana Medical AB (publ) meddelar idag att i enlighet med beslut p&aring; &aring;rsst&auml;mman den 19 maj 2020 har styrelsens ordf&ouml;rande kontaktat bolagets tre r&ouml;stm&auml;ssigt st&ouml;rsta &auml;gare eller &auml;gargrupper som var och en erbj&ouml;ds att utse en representant att, tillsammans med styrelsens ordf&ouml;rande, utg&ouml;ra valberedning. Sedana Medicals valberedning inf&ouml;r &aring;rsst&auml;mman 2021 utg&ouml;rs av: Thomas Eklund, styrelseordf&ouml;rande [&hellip;]","og_url":"https:\/\/sedanamedical.com\/sv\/mfn_news\/sedana-medicals-valberedning-utsedd-4\/","og_site_name":"Sedana Medical","article_modified_time":"2025-05-26T08:27:08+00:00","twitter_card":"summary_large_image","twitter_misc":{"Ber\u00e4knad l\u00e4stid":"3 minuter"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"WebPage","@id":"https:\/\/sedanamedical.com\/sv\/mfn_news\/sedana-medicals-valberedning-utsedd-4\/","url":"https:\/\/sedanamedical.com\/sv\/mfn_news\/sedana-medicals-valberedning-utsedd-4\/","name":"Sedana Medicals valberedning utsedd - Sedana Medical","isPartOf":{"@id":"https:\/\/sedanamedical.com\/#website"},"datePublished":"2020-10-23T11:00:00+00:00","dateModified":"2025-05-26T08:27:08+00:00","breadcrumb":{"@id":"https:\/\/sedanamedical.com\/sv\/mfn_news\/sedana-medicals-valberedning-utsedd-4\/#breadcrumb"},"inLanguage":"sv-SE","potentialAction":[{"@type":"ReadAction","target":["https:\/\/sedanamedical.com\/sv\/mfn_news\/sedana-medicals-valberedning-utsedd-4\/"]}]},{"@type":"BreadcrumbList","@id":"https:\/\/sedanamedical.com\/sv\/mfn_news\/sedana-medicals-valberedning-utsedd-4\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/sedanamedical.com\/sv\/hem\/"},{"@type":"ListItem","position":2,"name":"MFN News Items","item":"https:\/\/sedanamedical.com\/mfn_news\/"},{"@type":"ListItem","position":3,"name":"Sedana Medicals valberedning utsedd"}]},{"@type":"WebSite","@id":"https:\/\/sedanamedical.com\/#website","url":"https:\/\/sedanamedical.com\/","name":"Sedana Medical","description":"Inhaled Sedation","publisher":{"@id":"https:\/\/sedanamedical.com\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/sedanamedical.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"sv-SE"},{"@type":"Organization","@id":"https:\/\/sedanamedical.com\/#organization","name":"Sedana Medical","url":"https:\/\/sedanamedical.com\/","logo":{"@type":"ImageObject","inLanguage":"sv-SE","@id":"https:\/\/sedanamedical.com\/#\/schema\/logo\/image\/","url":"https:\/\/i0.wp.com\/sedanamedical.com\/wp-content\/uploads\/2024\/05\/sm_icon_neg.png?fit=787%2C1182&ssl=1","contentUrl":"https:\/\/i0.wp.com\/sedanamedical.com\/wp-content\/uploads\/2024\/05\/sm_icon_neg.png?fit=787%2C1182&ssl=1","width":787,"height":1182,"caption":"Sedana Medical"},"image":{"@id":"https:\/\/sedanamedical.com\/#\/schema\/logo\/image\/"}}]}},"jetpack_likes_enabled":true,"jetpack_sharing_enabled":true,"_links":{"self":[{"href":"https:\/\/sedanamedical.com\/sv\/wp-json\/wp\/v2\/mfn_news\/2296","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/sedanamedical.com\/sv\/wp-json\/wp\/v2\/mfn_news"}],"about":[{"href":"https:\/\/sedanamedical.com\/sv\/wp-json\/wp\/v2\/types\/mfn_news"}],"wp:attachment":[{"href":"https:\/\/sedanamedical.com\/sv\/wp-json\/wp\/v2\/media?parent=2296"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}